1-1806503-A-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP2PP3PP5_Very_Strong
The ENST00000378609.9(GNB1):c.239T>A(p.Ile80Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,611,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I80S) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000378609.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNB1 | NM_002074.5 | c.239T>A | p.Ile80Asn | missense_variant | 6/12 | ENST00000378609.9 | NP_002065.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNB1 | ENST00000378609.9 | c.239T>A | p.Ile80Asn | missense_variant | 6/12 | 1 | NM_002074.5 | ENSP00000367872 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251124Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135726
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1459226Hom.: 0 Cov.: 28 AF XY: 0.00000413 AC XY: 3AN XY: 726042
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74354
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 42 Pathogenic:2Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 02, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Oct 02, 2021 | Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogeic with strong evidence (ClinVar ID: VCV000224715.5, PMID 27108799 and 25485910, PS1). The missense variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported (PM1). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000004). A different missense change at the same codon (p.Ile80Ser) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000391609.2, PM5).The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). Missense changes are a common disease-causing mechanism (PP2). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Acute lymphoid leukemia Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 02, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 29, 2022 | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GNB1 protein function. ClinVar contains an entry for this variant (Variation ID: 224715). This missense change has been observed in individual(s) with GNB1-related conditions (PMID: 27108799, 32901917). In at least one individual the variant was observed to be de novo. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces isoleucine, which is neutral and non-polar, with asparagine, which is neutral and polar, at codon 80 of the GNB1 protein (p.Ile80Asn). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 01, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35119134, 25485910, 27108799, 32901917, 35719373, 34522861) - |
Hypotonia;C0036572:Seizure;C0232466:Feeding difficulties;C0270834:Focal impaired awareness seizure;C0456070:Growth delay;C0557874:Global developmental delay;C1838391:Limb hypertonia;C1860834:Infantile muscular hypotonia;C2315100:Failure to thrive;C4021219:Multifocal epileptiform discharges;C4048268:Cerebral visual impairment Pathogenic:1
Pathogenic, no assertion criteria provided | research | Genomics And Bioinformatics Analysis Resource, Columbia University | Feb 10, 2016 | - - |
Hypotonia;C0036572:Seizure;na:Neurodevelopmental Disability Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | May 05, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at